Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Capital Expenditures (2016 - 2026)

Healthstream has reported Capital Expenditures over the past 16 years, most recently at -$3.0 million for Q4 2025.

  • Quarterly Capital Expenditures fell 276.22% to -$3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $475000.0 through Dec 2025, up 19.05% year-over-year, with the annual reading at $475000.0 for FY2025, 19.05% up from the prior year.
  • Capital Expenditures was -$3.0 million for Q4 2025 at Healthstream, down from $3.4 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $16.2 million in Q3 2022 and troughed at -$16.7 million in Q4 2022.
  • The 5-year median for Capital Expenditures is $271500.0 (2023), against an average of $360900.0.
  • The largest YoY upside for Capital Expenditures was 8213.33% in 2022 against a maximum downside of 2144.79% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $815000.0 in 2021, then tumbled by 2144.79% to -$16.7 million in 2022, then surged by 102.08% to $346000.0 in 2023, then crashed by 330.92% to -$799000.0 in 2024, then crashed by 276.22% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Capital Expenditures are -$3.0 million (Q4 2025), $3.4 million (Q3 2025), and -$110000.0 (Q2 2025).